Health ❯ Healthcare ❯ Pharmacology

Drug Therapy

Combination Therapy BTK Inhibitors JAK Inhibitors EGFR Inhibitors Dual Antiplatelet Therapy Mitotane Statins and Ezetimibe Belantamab Mafodotin Aspirin and Ticagrelor Pirtobrutinib Monoclonal Antibodies Pazopanib PCSK9 Inhibitors Belnacasan

Evolocumab Cuts First Cardiovascular Events by 31% in High‑Risk Diabetes Without Known Atherosclerosis

The ACC 2026 analysis signals earlier, more aggressive LDL cholesterol lowering could reshape primary prevention for patients with diabetes.

Padcev–Keytruda Cuts Recurrence and Death Risk in Cisplatin-Ineligible Muscle-Invasive Bladder Cancer

Final FLAURA2 Data Show Osimertinib Plus Chemotherapy Extends Survival in EGFR-Mutant Lung Cancer

Phase 3 Trial Finds Tukysa Improves PFS in First-Line Maintenance for HER2-Positive Metastatic Breast Cancer

TACSI Trial Finds No Benefit of Dual Antiplatelet Therapy After CABG, Higher Bleeding Risk

ESC Trials Back Shorter Antiplatelet Therapy for Selected MI Patients

Inhibiting Pyroptosis with Belnacasan Resensitizes Bladder Tumors to Chemotherapy